SEC reporting owner

Geffken Daniel E. SEC insider disclosures

Explore Geffken Daniel E.'s reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001314756
Issuers
8
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Cyberkinetics Neurotechnology Systems, Inc.0001180253CYKN.BONoYes
Marina Biotech, Inc.0000737207MRNAYesNo
WINDTREE THERAPEUTICS INC /DE/0000946486WINTNoYes
Locust Walk Acquisition Corp.0001828522LWACYesNo
Eloxx Pharmaceuticals, Inc.0001035354ELOXYesNo
CERO THERAPEUTICS HOLDINGS, INC.0001870404PBAX, CEROYesNo
ProMIS Neurosciences Inc.0001374339PMNYesNo
CalciMedica, Inc.0001534133CALCYesNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.